PDT, Ramus Medical Technologies deal

PDTI's PDT Cardiovascular Inc. subsidiary and Ramus will explore the use of light activated drugs as an adjunct to bypass surgery to improve the patency (openness) and life of grafts in coronary and peripheral artery bypass procedures. The collaboration will combine photodynamic therapy with Ramus's Rapidgraft technology, which is used to build blood vessel grafts made from the patient's own non-vascular tissue. ...